These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7039004)

  • 1. A randomized trial of aspirin and sulfinpyrazone in patients with TIA.
    Candelise L; Landi G; Perrone P; Bracchi M; Brambilla G
    Stroke; 1982; 13(2):175-9. PubMed ID: 7039004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of aspirin and sulfinpyrazone in threatened stroke.
    Canadian Cooperative Study Group
    N Engl J Med; 1978 Jul; 299(2):53-9. PubMed ID: 351394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
    Friedman LM
    Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues.
    Gent M; Barnett HJ; Sackett DL; Taylor DW
    Circulation; 1980 Dec; 62(6 Pt 2):V97-105. PubMed ID: 7002357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.
    Cairns JA; Gent M; Singer J; Finnie KJ; Froggatt GM; Holder DA; Jablonsky G; Kostuk WJ; Melendez LJ; Myers MG
    N Engl J Med; 1985 Nov; 313(22):1369-75. PubMed ID: 3903504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversy in neurology: the Canadian study on TIA and aspirin. A critique of the Canadian TIA study.
    Kurtzke JF
    Ann Neurol; 1979 Jun; 5(6):597-9. PubMed ID: 382978
    [No Abstract]   [Full Text] [Related]  

  • 7. Controversy in neurology: the Canadian study on TIA and aspirin. A critique of the Canadian TIA study. Reply.
    Barnett HJ; Gent M; Sackett DL; Taylor DW
    Ann Neurol; 1979 Jun; 5(6):599-601. PubMed ID: 382979
    [No Abstract]   [Full Text] [Related]  

  • 8. Does platelet antiaggregant therapy lessen the severity of stroke?
    Grotta JC; Lemak NA; Gary H; Fields WS; Vital D
    Neurology; 1985 May; 35(5):632-6. PubMed ID: 3887210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trial of aspirin in cerebral ischemia.
    Fields WS; Lemak NA; Frankowski RF; Hardy RJ
    Stroke; 1977; 8(3):301-14. PubMed ID: 324036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized clinical trial of pentoxifylline and antiaggregants in recent transient ischemic attacks (TIA). A one year follow-up.
    Herskovits E; Vazquez A; Famulari A; Tamaroff L; Fraiman H; Gonzáles AM; Smud R; Vila J; Matera V
    Ric Clin Lab; 1981; 11 Suppl 1():257-64. PubMed ID: 6765140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin in transient ischemic attacks and minor stroke: a meta-analysis.
    Stachenko SJ; Bravo G; Côté R; Boucher J; Battista RN
    Fam Pract Res J; 1991 Jun; 11(2):179-91. PubMed ID: 1829313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversy in the interpretation of clinical trials.
    Armitage P
    Ann Neurol; 1979 Jun; 5(6):601-2. PubMed ID: 382980
    [No Abstract]   [Full Text] [Related]  

  • 13. Controlled trial of aspirin in cerebral ischemia.
    Fields WS; Lemak NA; Frankowski RF; Hardy RJ; Bigelow RH
    Circulation; 1980 Dec; 62(6 Pt 2):V90-6. PubMed ID: 7002356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 15. Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study.
    Sorensen PS; Pedersen H; Marquardsen J; Petersson H; Heltberg A; Simonsen N; Munck O; Andersen LA
    Stroke; 1983; 14(1):15-22. PubMed ID: 6337425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of platelets in transient ischemic attacks and cerebral vascular accidents.
    Barnett HJ
    Adv Exp Med Biol; 1978; 102():257-63. PubMed ID: 685753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.
    Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Hill MD; Jonasson J; Kasner SE; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
    Lancet Neurol; 2017 Apr; 16(4):301-310. PubMed ID: 28238711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the management of transient ischemic attacks.
    Sandok BA; Furlan AJ; Whisnant JP; Sundt TM
    Mayo Clin Proc; 1978 Oct; 53(10):665-74. PubMed ID: 362079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet agents in the secondary prevention of stroke: meta-analysis of the randomized control trials.
    Sze PC; Reitman D; Pincus MM; Sacks HS; Chalmers TC
    Stroke; 1988 Apr; 19(4):436-42. PubMed ID: 3284017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.